Global RNAi Therapeutics Market Insights & Forecasts With Potential Impact of COVID-19 2024-2028 Featuring Sanofi, Alnylam, Arrowhead, Arbutus Biopharma, Benitec Biopharma, Sirnaomics - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global RNAi Therapeutics Market (By Molecule Type, Application, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)" report has been add

BusinesswireMay 3 21:35

Chardan Capital Reiterates Buy on Arbutus Biopharma, Maintains $4 Price Target

Chardan Capital analyst Keay Nakae reiterates Arbutus Biopharma with a Buy and maintains $4 price target.

Analyst UpgradesMay 3 21:21

Analysts Have Conflicting Sentiments on These Healthcare Companies: Arbutus Biopharma (ABUS), Neurocrine (NBIX) and Bausch Health Companies (BHC)

TipRanksMay 3 19:11

Analysts Are Bullish on Top Healthcare Stocks: Arbutus Biopharma (ABUS), Lemaitre Vascular (LMAT)

TipRanksMay 3 12:30

Earnings Call Summary | Arbutus Biopharma(ABUS.US) Q1 2024 Earnings Conference

The following is a summary of the Arbutus Biopharma Corporation (ABUS) Q1 2024 Earnings Call Transcript:Financial Performance:Arbutus ended Q1 2024 with cash, cash equivalents, and investments of arou

Futu NewsMay 3 06:21 · Conference Call

Arbutus Biopharma Corp Reports Q1 2024 Earnings: A Detailed Financial Review

Yahoo FinanceMay 2 20:58